ArticleThe American journal of case reports2021

Hepatic AL Amyloidosis without Significant Light Chain Elevation in a Patient Treated with CyBorD Plus Daratumumab.

Brad Rybinski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.